The nocebo effect might affect treatment expectations in patients with burning mouth syndrome

Affiliations

¹ Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Milano, Italy E-mail address: elena.varoni@unimi.it (E. M. Varoni).

Comment

Elena Maria Varoni et al. Pain. 2015 Feb.

. 2015 Feb;156(2):356.

doi: 10.1097/01.j.pain.0000460317.65734.e4.

¹ Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Milano, Italy E-mail address: elena.varoni@unimi.it (E. M. Varoni).

No abstract available

Comment on

The magnitude of nocebo effects in pain: a meta-analysis.
Petersen GL, Finnerup NB, Colloca L, Amanzio M, Price DD, Jensen TS, Vase L. Petersen GL, et al. Pain. 2014 Aug;155(8):1426-1434. doi: 10.1016/j.pain.2014.04.016. Epub 2014 Apr 26. Pain. 2014. PMID: 24780622 Free PMC article.

1. Amenábar JM, Pawlowski J, Hilgert JB, Hugo FN, Bandeira D, Lhüller F, Lopes de Souza MA. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:460–5.
1. Bingel U. Placebo competence team. Avoiding nocebo effects to optimize treatment outcome. JAMA 2014;312:693–4.
1. Clark GT. Nocebo-responsive patients and topical pain control agents used for orofacial and mucosal pain. In: Clark GT, Dionne R, Pain Orofacial, editors. A Guide to Medications and Management. John Wiley & Sons, Inc., New York. 2012;5:84–94.
1. Faasse K, Petrie KJ. The nocebo effect: patient expectations and medication side effects. Postgrad Med J 2013;89:540–6.
1. Khan SA, Keaser ML, Meiller TF, Seminowicz DA. Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome. PAIN 2014;155:1472–80.